(Q34655287)

3 August 2017

title

Nanoparticles in medicine: therapeutic applications and developments (English)

1 reference

3 August 2017

0 references

Zhang L

1

1 reference

3 August 2017

Gu FX

2

1 reference

3 August 2017

Chan JM

3

1 reference

3 August 2017

Wang AZ

4

1 reference

3 August 2017

Langer RS

5

1 reference

3 August 2017

Farokhzad OC

6

1 reference

3 August 2017

language of work or name

English

0 references

publication date

24 October 2007

1 reference

Clinical Pharmacology & Therapeutics

3 August 2017

published in

1 reference

3 August 2017

volume

83

1 reference

3 August 2017

issue

5

1 reference

3 August 2017

page(s)

761-769

1 reference

Nanomedicine: developing smarter therapeutic and diagnostic modalities

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100400

7 January 2021

Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100400

7 January 2021

Nanoparticle and targeted systems for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100400

7 January 2021

Nanotechnology, nanomedicine, and the development of new, effective therapies for cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100400

7 January 2021

Targeted nanoparticle-based drug delivery and diagnosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100400

7 January 2021

Nanoparticle-based diagnosis and therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100400

7 January 2021

The emerging nanomedicine landscape

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100400

7 January 2021

How to stabilize phospholipid liposomes (using nanoparticles).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100400

7 January 2021

Recent advances with liposomes as pharmaceutical carriers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100400

7 January 2021

Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100400

7 January 2021

Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100400

7 January 2021

Polymer conjugates as anticancer nanomedicines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100400

7 January 2021

Tumor targeting based on the effect of enhanced permeability and retention (EPR) and the mechanism of receptor-mediated endocytosis (RME).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100400

7 January 2021

Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100400

7 January 2021

The origin of pegnology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100400

7 January 2021

Nanoparticle albumin-bound paclitaxel for metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100400

7 January 2021

Controlling liposome blood clearance by surface-grafted polymers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100400

7 January 2021

On the formulation of pH-sensitive liposomes with long circulation times.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100400

7 January 2021

Phase I and pharmacokinetic (PK) study of MAG-CPT (PNU 166148): a polymeric derivative of camptothecin (CPT)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100400

7 January 2021

Phase I and pharmacologic study of PKI166, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100400

7 January 2021

Improved oral delivery of paclitaxel following administration in nanoemulsion formulations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100400

7 January 2021

Dendrimers as drugs: discovery and preclinical and clinical development of dendrimer-based microbicides for HIV and STI prevention

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100400

7 January 2021

Dendritic cell function after gene transfer with adenovirus-calcium phosphate co-precipitates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100400

7 January 2021

Liposome-mediated targeting of enzymes to cancer cells for site-specific activation of prodrugs: comparison with the corresponding antibody-enzyme conjugate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100400

7 January 2021

Targeting of daunomycin using biotinylated immunoliposomes: pharmacokinetics, tissue distribution and in vitro pharmacological effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100400

7 January 2021

Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100400

7 January 2021

In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100400

7 January 2021

Polymersome encapsulated hemoglobin: a novel type of oxygen carrier.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100400

7 January 2021

Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100400

7 January 2021

In vitro and in vivo antitumor activity of the novel derivatized polyvinyl alcohol-based polymer P10(4).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100400

7 January 2021

Micellar nanocarriers: pharmaceutical perspectives

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100400

7 January 2021

Co-delivery of hydrophobic and hydrophilic drugs from nanoparticle-aptamer bioconjugates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100400

7 January 2021

Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100400

7 January 2021

PEGylated peptide dendrimeric carriers for the delivery of antimalarial drug chloroquine phosphate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100400

7 January 2021

Poly (propyleneimine) dendrimer based nanocontainers for targeting of efavirenz to human monocytes/macrophages in vitro.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100400

7 January 2021

Dendrimer-encapsulated camptothecins: increased solubility, cellular uptake, and cellular retention affords enhanced anticancer activity in vitro.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100400

7 January 2021

Improvement of cationic albumin conjugated pegylated nanoparticles holding NC-1900, a vasopressin fragment analog, in memory deficits induced by scopolamine in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100400

7 January 2021

Surfactant-polymer nanoparticles: a novel platform for sustained and enhanced cellular delivery of water-soluble molecules

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100400

7 January 2021

Self-assembled nanoparticles based on glycol chitosan bearing hydrophobic moieties as carriers for doxorubicin: in vivo biodistribution and anti-tumor activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100400

7 January 2021

Hybrid virus-polymer materials. 1. Synthesis and properties of PEG-decorated cowpea mosaic virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100400

7 January 2021

Covalently linked Au nanoparticles to a viral vector: potential for combined photothermal and gene cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100400

7 January 2021

The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100400

7 January 2021

Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100400

7 January 2021

Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100400

7 January 2021

A new class of silica cross-linked micellar core-shell nanoparticles

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100400

7 January 2021

Identifiers

DOI

10.1038/SJ.CLPT.6100400

1 reference

Dimensions Publication ID

3 August 2017

1004414839

0 references

1 reference